Health-tech Archives

Early-stage results of the company’s AI chest x-ray solution across the NHS in Scotland show Harrison.ai could save 600 lives a year in the country.

By targeting RNA rather than DNA, Amber Bio aims to treat multiple genetic diseases with fewer safety risks.